Drug Type Monoclonal antibody |
Synonyms TBL 100, TBL-100 |
Target |
Action inhibitors |
Mechanism TAU inhibitors(Microtubule-associated protein tau inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Frontotemporal Dementia | Preclinical | United Kingdom | 07 Feb 2018 | |
Supranuclear Palsy, Progressive | Preclinical | United Kingdom | 07 Feb 2018 | |
Alzheimer Disease | Preclinical | United States | - |